Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 28, Issue 4, 2004, Pages 709-713

  Pirildar, Şebnem ^a   Gönül, Ali Saffet ^a   Taneli, Fatma ^b   Akdeniz, Fisun ^a  

^a EGE UNIVERSITY   (Turkey)

^b CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Antipsychotics; BDNF; Brain derived neurotrophic factor; brain derived neurotrophic factor; PANSS; positive and negative syndrome rating scale; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; NEUROTROPHIC FACTOR; OLANZAPINE; RISPERIDONE;

ADOLESCENT; ADULT; AGE; ARTICLE; BRAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; EVALUATION; FEMALE; HUMAN; MALE; MENTAL DISEASE; MENTAL HEALTH; PATIENT; PROTEIN BLOOD LEVEL; RECORDING; SCHIZOPHRENIA; SCORING SYSTEM; SEX; SYMPTOM;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BIOLOGICAL MARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA;

EID: 3342996086     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2004.05.008     Document Type: Article

References (32)

1. Altar C.A., Cai N., Bliven T., Juhasz M., Conner J.M., Acheson A.L., Lindsay R.M., Wiegand S.J. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature. 389:1997;856-860
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 4th ed.:1994;American Psychiatric Press, Washington, DC
3. Brouha A.K., Shannon W.C., Hyde T.M., Herman M.M., Murray A.M., Bigelow L.B., Weinberger D.R., Kleinman J.E. Reductions in brain-derived neurotrophic factor mRNA in the hippocampus of patients with schizophrenia. Abstr.-Soc. Neurosci. 22:1996;1680
4. Dawson N.M., Hamid E.H., Egan M.F., Meredith G.E. Changes in the pattern of brain-derived neurotrophic factor immunoreactivity in the rat brain after acute and subchronic haloperidol treatment. Synapse. 39:2001;70-81
5. Duman R.S., Heninger G.R., Nestler E.J. Adaptations of receptor-coupled signal transduction pathways underlying stress and drug induced neuronal plasticity. J. of Nerv. Ment. Dis. 182:1994;692-700
6. Duman R.S., Malberg J., Nakagawa S., D'Sa C. Neuronal plasticity and survival in mood disorders. Biol. Psychiatry. 48:2000;732-739
7. Durany N., Michel T., Zochling R., Boissl K.W., Cruz-Sanchez F.F., Riederer P., Thome J. Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr. Res. 52:2001;79-86
8. Figurov A., Pozzo-Miller L.D., Olefsson P., Wang T., Lu B. Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature. 381:1996;706-709
9. Fourney J.C., Ashe P., Nylen K., Juorio A.V., Li X.M. Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration. Brain Res. 954:2002;11-20
10. Friston K.J., Frith C.D. Schizophrenia: a disconnection syndrome? Clin. Neurosci. 3:1995;89-97
11. Fujimura H., Altar C.A., Chen R., Nakamura T., Nakahashi T., Kambayashi J., Sun B., Tandon N.N. Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb. Haemost. 87:2002;728-734
12. Karege F., Schwald M., Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci. Lett. 328:2002;261-264
13. Korte M., Carroll P., Wolf E., Brem G., Thoenen H., Bonhoeffer T. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. U. S. A. 92:1995;8865-8870
14. Linden A.M., Vaisanen J., Lakso M., Nawa H., Wong G., Castren E. Expression of neurotrophins BDNF and NT-3, and their receptors in rat brain after administration of antipsychotic and psychotropic agents. J. Mol. Neurosci. 14:2000;27-37
15. Lipska B.K., Khaing Z.Z., Weickert C.S., Weinberger D.R. BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs. Eur. J. Neurosci. 14:2001;135-144
16. McAllister A.K., Katz L.C., Lo D.C. Neurotrophins and synaptic plasticity. Annu. Rev. Neurosci. 22:1999;295-318
17. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15:1995;7539-7547
18. Pan W., Banks W.A., Fasold M.B., Bluth J., Kastin A.J. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology. 37:1998;1553-1561
19. Parikh V., Khan M.M., Mahadik S.P. Olanzapine counteracts reduction of brain-derived neurotropic factor and Trk B receptors in rat hippocampus produced by haloperidol. Neuroscience Lett. 356(2):2004;135-139
20. Pearse H.E. The APUD concept and hormone production. Clin. Endocrinol. Metab. 9:1980;211-222
21. Radka S.F., Holst P.A., Fritsche M., Altar C.A. Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Res. 709:1996;122-130
22. Sajatovic M., Meltzer H.Y. The effect of short-term electroconvulsive treatment plus neuroleptics in treatment-resistant schizophrenia and schizoaffective disorders. Convuls. Ther. 9:1993;167-175
23. Shimizu E., Hashimato K., Watanabe H., Komatsu N., Okamura N., Koike K., Shinado N., Nakazato M., Kumakiri N., Okada S.O., Iyo M. Serum brain-derived neurotrophic factor (BDNF levels in schizophrenia are indistinguishable from controls. Neurosci. Lett. 351(2):2003;111-114
24. Smith M.A., Makino S., Kim S.Y., Kvetnansky R., Post R.M. Stress increases brain-derived neurotrophic factor messenger ribonucleic acid in the hypothalamus and pituitary. Endocrinology. 136:1995;3743-3750
25. Takahashi M., Shirakawa O., Toyooka K., Kitamura N., Hashimato T., Maeda K., Koizumu S., Wakabayashi K., Takahashi H., Someya T., Nawa H. Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Mol. Psychiatry. 5:2000;293-300
26. Thoenen H. Neurotrophins and neuronal plasticity. Science. 270:1995;593-598
27. Toyooka K., Shirakawa O., Kitamura N., Hashimato T., Maeda K., Wakabayashi K., Takahashi H., Someya T., Nawa H. Large individual variation in BDNF content in human brain and serum. Abstr.-Soc. Neurosci. 25:1999;515
28. Toyooka K., Asama K., Watanabe Y., Muratake T., Takahashi M., Someya T., Nawa H. Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res. 110:2002;249-257
29. Vaidya V.A., Marek G.J., Aghajanian G.K., Duman R.S. 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J. Neurosci. 17:1997;2785-2795
30. Virgos C., Martorell L., Valero J., Figuera L., Civeira F., Joven J., Labad A., Vilella E. Association study of schizophrenia with polymorphisms at six candidate genes. Schizophr. Res. 49:2001;65-71
31. Weickert C.S., Hyde T.M., Lipska B.K., Herman M.M., Weinberger D.R., Kleinman J.E. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol. Psychiatry. 2003;592-610
32. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry. 44:1987;660-669